Cargando…

Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease

Fabry disease is a heritable lipid disorder caused by the low activity of α-galactosidase A and characterized by the systemic accumulation of globotriaosylceramide (Gb3). Recent studies have reported a structural heterogeneity of Gb3 in Fabry disease, including Gb3 isoforms with different fatty acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishii, Satoshi, Taguchi, Atsumi, Okino, Nozomu, Ito, Makoto, Maruyama, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2020
Materias:	Methods and Resources
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186183/ https://www.ncbi.nlm.nih.gov/pubmed/32179651 http://dx.doi.org/10.1074/jbc.RA120.012665

Ejemplares similares

Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease
por: Taguchi, Atsumi, et al.
Publicado: (2023)

Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease
por: Üçeyler, Nurcan, et al.
Publicado: (2016)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
por: Tsukimura, Takahiro, et al.
Publicado: (2021)

A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse
por: Shin, Seok-Ho, et al.
Publicado: (2018)

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion
por: Kamani, Mustafa A, et al.
Publicado: (2016)

Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy
por: Gaggl, Martina, et al.
Publicado: (2016)

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012)

Low bone mineral density due to secondary hyperparathyroidism in the Gla(tm)Tg(CAG‐A4GALT) mouse model of Fabry disease
por: Maruyama, Hiroki, et al.
Publicado: (2020)

Medullary thick ascending limb impairment in the Gla(tm)Tg(CAG-A4GALT) Fabry model mice
por: Maruyama, Hiroki, et al.
Publicado: (2018)

Quantitative proteome comparison of human hearts with those of model organisms
por: Linscheid, Nora, et al.
Publicado: (2021)

Serum Globotriaosylceramide Assay as a Screening Test for Fabry Disease in Patients with ESRD on Maintenance Dialysis in Korea
por: Kim, Jeong-Yup, et al.
Publicado: (2010)

A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients
por: Alharbi, Fahad J., et al.
Publicado: (2016)

Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy
por: Liguori, Rocco, et al.
Publicado: (2017)

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model
por: Li, Rui, et al.
Publicado: (2020)

One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease
por: Najafian, Behzad, et al.
Publicado: (2016)

A systems genetics resource and analysis of sleep regulation in the mouse
por: Diessler, Shanaz, et al.
Publicado: (2018)

Construction and validation of customized genomes for human and mouse ribosomal DNA mapping
por: George, Subin S., et al.
Publicado: (2023)

Role of Globotriaosylceramide in Physiology and Pathology
por: Celi, Ana Beatriz, et al.
Publicado: (2022)

Single-cell RNA-seq analysis of mouse preimplantation embryos by third-generation sequencing
por: Fan, Xiaoying, et al.
Publicado: (2020)

Meiotic Cas9 expression mediates gene conversion in the male and female mouse germline
por: Weitzel, Alexander J., et al.
Publicado: (2021)

Molecular characterization of nervous system organization in the hemichordate acorn worm Saccoglossus kowalevskii
por: Andrade López, José M., et al.
Publicado: (2023)

Assessing the replicability of spatial gene expression using atlas data from the adult mouse brain
por: Lu, Shaina, et al.
Publicado: (2021)

Integrated transcriptomics and epigenomics reveal chamber-specific and species-specific characteristics of human and mouse hearts
por: Gao, Junpeng, et al.
Publicado: (2021)

Bellymount enables longitudinal, intravital imaging of abdominal organs and the gut microbiota in adult Drosophila
por: Koyama, Leslie Ann Jaramillo, et al.
Publicado: (2020)

Quantifying the effects of temperature on mosquito and parasite traits that determine the transmission potential of human malaria
por: Shapiro, Lillian L. M., et al.
Publicado: (2017)

A single-cell atlas of the sexually dimorphic Drosophila foreleg and its sensory organs during development
por: Hopkins, Ben R., et al.
Publicado: (2023)

Inhibition of tumor angiogenesis by globotriaosylceramide immunotargeting
por: Birklé, Stéphane, et al.
Publicado: (2013)

Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types
por: Welford, R W D, et al.
Publicado: (2018)

Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease
por: Shiga, Tomoko, et al.
Publicado: (2021)

The Brain/MINDS Marmoset Connectivity Resource: An open-access platform for cellular-level tracing and tractography in the primate brain
por: Skibbe, Henrik, et al.
Publicado: (2023)

Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry disease
por: An, Jong Hun, et al.
Publicado: (2022)

Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable GLA mutations following 6 months of migalastat treatment
por: Mauer, Michael, et al.
Publicado: (2017)

MiRNA Let-7a and Let-7d Are Induced by Globotriaosylceramide via NF-kB Activation in Fabry Disease
por: Maier, Nadine, et al.
Publicado: (2021)

Spontaneous Accumulation of Globotriaosylceramide (Gb3) in Proximal Renal Tubules in an ICR Mouse
por: Mutsuga, Mayu, et al.
Publicado: (2013)

Systematic analysis of transcription start sites in avian development
por: Lizio, Marina, et al.
Publicado: (2017)

Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort
por: Maruyama, Hiroki, et al.
Publicado: (2021)

Data-driven analyses of motor impairments in animal models of neurological disorders
por: Ryait, Hardeep, et al.
Publicado: (2019)

Vascularized human cortical organoids (vOrganoids) model cortical development in vivo
por: Shi, Yingchao, et al.
Publicado: (2020)

Fully automated leg tracking of Drosophila neurodegeneration models reveals distinct conserved movement signatures
por: Wu, Shuang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5b2tfobpk6bsru4omj7ov78a1u